U.S. pharma huge copyright scrapped two experimental weight loss products last 12 months—a as soon as-daily pill, lotiglipron, on account of elevated liver enzymes and a twice-each day capsule, danuglipron, as a result of potent Unintended effects—but CEO Albert Bourla has mentioned the company is set to “Enjoy and earn” within the obesity